MeiraGTx Holdings plc (MGTX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $932.32M; Treasury Stock, Common, ValueUSD $18.19M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $3.25M.
- 2026-03-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $820.02M; Treasury Stock, Common, ValueUSD $18.19M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.58M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $808.02M; Treasury Stock, Common, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.41M.
- 2025-09-30: Common Stock, Value, IssuedUSD $3.00K; Additional Paid in CapitalUSD $797.06M; Treasury Stock, Common, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-6.31M.
MeiraGTx Holdings plc Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.00K | $932.32M | $18.19M | $3.25M | $-701.82M | (m) | $215.78M | (m) | (m) | 3 month · $3.00K | 3 month · $673.00K | (m) | (m) |
| 2026-03-31 | $3.00K | $820.02M | $18.19M | $2.58M | $-862.54M | $-58.13M | $-58.13M | 3 month · $18.19M | 3 month · $35.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.00K | $808.02M | (m) | $2.41M | $-816.22M | $-5.79M | $-5.79M | (m) | 12 month · $-11.00K | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.00K | $797.06M | (m) | $-6.31M | $-831.31M | $-40.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.00K | $791.28M | (m) | $-7.53M | $-780.80M | $2.96M | $2.96M | (m) | 3 month · $14.00K | (m) | (m) | (m) | (m) |
| 2025-03-31 | $3.00K | $780.16M | (m) | $-5.07M | $-742.00M | $33.10M | $33.10M | (m) | 3 month · $12.00K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $3.00K | $773.57M | (m) | $-3.72M | $-702.02M | $67.83M | $67.83M | (m) | 12 month · $657.00K | (m) | (m) | (m) | (m) |
| 2024-09-30 | $3.00K | $763.20M | (m) | $-4.85M | $-662.62M | $95.74M | (m) | (m) | 3 month · $1.86M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $3.00K | $706.94M | (m) | $-3.61M | $-623.29M | $80.04M | (m) | (m) | 3 month · $9.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | $2.00K | $699.53M | (m) | $-3.13M | $-574.67M | $121.73M | (m) | (m) | 3 month · $635.00K | (m) | (m) | (m) | (m) |
| 2023-12-31 | $2.00K | $693.84M | (m) | $-1.44M | $-554.23M | $138.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $2.00K | $659.17M | (m) | $7.16M | $-574.45M | $91.89M | (m) | (m) | 3 month · $116.00K | (m) | (m) | (m) | (m) |
| 2023-06-30 | $2.00K | $652.52M | (m) | $1.15M | $-530.15M | $123.53M | (m) | (m) | 3 month · $4.00M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $2.00K | $587.09M | (m) | $3.69M | $-500.57M | $90.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $2.00K | $581.89M | (m) | $6.05M | $-470.20M | $117.74M | (m) | (m) | (m) | (m) | (m) | 12 month · $2.27M | (m) |
| 2022-09-30 | $2.00K | $550.17M | (m) | $15.39M | $-442.89M | $122.67M | (m) | (m) | (m) | (m) | (m) | 3 month · $2.27M | (m) |
| 2022-06-30 | $2.00K | $540.96M | (m) | $6.62M | $-405.61M | $141.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $2.00K | $533.65M | (m) | $-739.00K | $-371.63M | $161.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $2.00K | $528.66M | (m) | $-2.67M | $-340.59M | $185.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $2.00K | $521.42M | (m) | $-2.91M | $-330.68M | $187.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $2.00K | $516.03M | (m) | $-5.58M | $-304.73M | $205.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $2.00K | $510.61M | (m) | $-5.17M | $-284.64M | $220.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $2.00K | $504.48M | (m) | $-4.90M | $-261.03M | $238.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.49K | $431.10M | (m) | $-1.45M | $-250.57M | $179.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $1.45K | $414.23M | (m) | $2.67M | $-244.14M | $172.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.43K | $401.49M | (m) | $2.15M | $-218.72M | $184.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.43K | $395.63M | (m) | $-1.79M | $-203.04M | $190.80M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $4.19M |
| 2019-09-30 | $1.42K | $390.05M | (m) | $2.39M | $-197.55M | $194.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $1.29K | $315.92M | (m) | $739.87K | $-187.09M | $129.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $1.29K | $311.53M | (m) | $-840.02K | $-166.27M | $144.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $1.06K | $229.05M | (m) | $293.67K | $-148.29M | $81.06M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $4.19M |
| 2018-09-30 | $1.05K | $223.87M | (m) | $-292.48K | $-127.23M | $96.34M | (m) | (m) | 3 month · $134.21K | (m) | (m) | (m) | 9 month · $4.19M |
| 2018-06-30 | $1.05K | $221.08M | (m) | $-801.24K | $-111.81M | $108.47M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $4.19M 6 month · $4.19M |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | $-60.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $342.00 | $20.08M | (m) | $-2.02M | $-65.42M | $-47.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $-17.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |